The fact that PIK3CA mutations and PTEN loss were nearly mutually exclusive implied that deregulated PI3K signaling is critical for tumorigenesis in breast cancers and that loss of either PIK3CA or PTEN abrogates the selective pressure for targeting of the other gene. This evidence concerns the gene PIK3CD and breast carcinoma.